News
The approval was based on data from the phase 1 ELEVATE-PLUS trials, which showed the acalabrutinib 100mg tablets were bioequivalent to the acalabrutinib 100mg capsules.
News
The approval was based on efficacy and safety data from a phase 3 trial, which included two 24-week treatment periods in patients 12 years of age and older with EoE.
Drugs in the Pipeline
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
News
Increased incidence of CAP was noted in stroke patients using PPIs.
News
Findings showed that children who were initiated on PPIs were 57% more likely to be diagnosed with asthma.
Drugs in the Pipeline
The bile acid sequestrant was designed to be maintained in the stomach over an extended period of time where it was expected to intercept bile before it reached the esophagus.
News
A recently published report describes the case of a 61-year-old male patient who experienced antacid-induced hypercalcemia and highlights the importance of performing thorough medication reconciliation.
AAAAI 2020
Prenatal exposure to calcium carbonate antacids was associated with the development of food protein-induced allergic proctocolitis, a type of delayed inflammatory gut food allergy to protein, in offspring.
News
Talicia (omeprazole magnesium, amoxicillin and rifabutin delayed-release capsules) has been made available for the treatment of Helicobacter pylori (H. pylori) infection in adults, according to RedHill Biopharma.
Generics News
Dr. Reddy’s Laboratories announced the launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, the generic equivalent to Vimovo® (Horizon Pharma).
